CSS2 Antibody

Shipped with Ice Packs
In Stock

Description

Absence of Direct References to "CSS2 Antibody"

None of the 11 search results (spanning antibody structure/function, SARS-CoV-2/RSV therapeutics, autoimmune disorders, and antibody databases) mention "CSS2 Antibody." Key areas explored include:

  • Neutralizing antibodies for SARS-CoV-2 (e.g., clesrovimab, O5C2) .

  • Autoantibodies like CASPR2, linked to neurological disorders .

  • Broadly reactive S2-targeting antibodies against coronaviruses .

  • Antibody databases tracking clinical-stage candidates .

This suggests that "CSS2 Antibody" may be:

  • A recently discovered compound not yet widely published.

  • A nomenclature error (e.g., confusion with CASPR2 Antibody, a validated autoimmune target ).

  • A proprietary or internal code name not disclosed in public repositories.

CASPR2 Antibody

A related autoantibody associated with autoimmune encephalitis and peripheral nerve hyperexcitability syndromes:

FeatureDetailsSource
Clinical PresentationLimbic encephalitis, Morvan syndrome, refractory epilepsy
Diagnostic MarkersSerum/CSF positivity (50.3% CSF detection rate)
Associated ConditionsThymoma (21.8%), myasthenia gravis
TreatmentImmunosuppression (e.g., corticosteroids, IVIG)

S2-Targeting Antibodies

Antibodies against the SARS-CoV-2 S2 subunit (e.g., C20.119) exhibit cross-reactive neutralization and ADCC activity:

AntibodyTarget EpitopeFunctionBreadth
C20.119Fusion peptide (FP)Neutralizes SARS-CoV-2 variants, SARS-CoV-1Sarbecoviruses, human coronaviruses
S2P6Conformational S2 epitopeADCC-mediated protectionSARS-CoV-2 variants
O5C2RBD-ACE2 interfaceBlocks viral entry; broad variant coverageAll tested SARS-CoV-2 variants

Recommendations for Further Research

To resolve ambiguity around "CSS2 Antibody":

  1. Verify Nomenclature: Confirm spelling and contextual usage (e.g., CASPR2 vs. CSS2).

  2. Explore Proprietary Databases: Check internal pharmaceutical pipelines or unpublished preclinical studies.

  3. Monitor Emerging Literature: Use platforms like PubMed, ClinicalTrials.gov, or the Coronavirus Antibody Database (CoV-RDB) .

Antibody Validation Resources

For future reference, key antibody data repositories include:

ResourceScopeLink
Stanford CoV-RDBSARS-CoV-2 neutralizing antibody datahttps://covdb.stanford.edu
The Antibody SocietyClinical-stage antibody therapeuticshttps://www.antibodysociety.org
Addgene Antibody RepositoryOpen-access antibody validation datahttps://blog.addgene.org

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
CSS2 antibody; YFR020WSecreted protein CSS2 antibody; Condition specific secretion protein 2 antibody
Target Names
CSS2
Uniprot No.

Target Background

Database Links

KEGG: sce:YFR020W

STRING: 4932.YFR020W

Subcellular Location
Secreted.

Q&A

What is CSS2 and why are antibodies against it important in research?

CSS2, also known as Chondroitin Polymerizing Factor, is an enzyme critical for chondroitin sulfate (CS) biosynthesis. It exists in multiple variants, with CSS2A and CSS2B being the most well-characterized. These variants play differential roles in CS biosynthesis, with CSS2A facilitating the process while CSS2B exhibits inhibitory effects. CSS2A and CSS2B are expressed in various tissues and localize in both the endoplasmic reticulum and Golgi apparatus .

Antibodies against CSS2 are vital research tools that enable the detection, localization, and functional analysis of CSS2 variants in cellular systems. They allow researchers to investigate the mechanisms of CS biosynthesis, which is essential for understanding developmental processes, tissue repair, and various pathological conditions involving extracellular matrix components.

How are anti-CSS2 antibodies typically generated for research applications?

The generation of anti-CSS2 antibodies typically follows a systematic approach involving several key steps:

  • Peptide design and synthesis: A specific synthetic peptide (e.g., AELERRFPGARVPWL, corresponding to amino acid residues 570-584 of CSS2A and 408-422 of CSS2B) is designed to serve as the antigenic determinant .

  • Immunization: The synthetic peptide with an N-terminal cysteine is used to immunize animals (commonly rabbits) to elicit an immune response .

  • Antibody purification: The resulting antiserum undergoes affinity purification using maleimide-Sepharose conjugated with the antigenic peptide to isolate specific anti-CSS2 antibodies .

  • Validation: The purified antibodies are validated through various techniques including Western blotting, immunoprecipitation, and immunofluorescence to confirm specificity and functionality.

This methodological approach ensures the production of antibodies with high specificity for CSS2, making them reliable tools for research applications.

What experimental techniques commonly employ CSS2 antibodies?

CSS2 antibodies are versatile research tools employed in multiple experimental techniques:

  • Immunoprecipitation: CSS2 antibodies can be used to isolate CSS2 and associated protein complexes from cell lysates, enabling the study of CSS2 interactions with other enzymes involved in CS biosynthesis .

  • Western blotting: This technique allows for the detection and quantification of CSS2 variants in tissue or cellular samples, providing insights into their expression levels under different conditions.

  • Immunofluorescence: CSS2 antibodies enable visualization of the subcellular localization of CSS2 variants, confirming their presence in the ER and Golgi apparatus .

  • Flow cytometry: For analyzing CSS2 expression in individual cells within heterogeneous populations.

  • Chromatin immunoprecipitation (ChIP): If studying transcriptional regulation of CSS2 genes.

Each technique requires specific optimization of antibody concentration, incubation conditions, and detection methods to ensure reliable and reproducible results.

How can researchers distinguish between CSS2A and CSS2B variants using antibodies?

Distinguishing between CSS2A and CSS2B variants presents a significant challenge due to their structural similarities. Researchers can employ multiple complementary approaches:

  • Variant-specific antibodies: While challenging to develop, antibodies targeting unique regions in CSS2A (such as the transmembrane domain absent in CSS2B) would enable specific detection .

  • Combined immunological and molecular approaches: Researchers can use TaqMan probes and primers specific for individual CSS2 variants alongside antibody-based techniques. For CSS2A, probes such as 5′-6-carboxyfluorescein-TAGACCCCACCTCGGGGGCGGGGCC-6-carboxytetramethylrhodamine (TAMRA)-3′ with specific primers can be employed, while for CSS2B, different probes like 5′-tetrachloro-6-carboxy-fluorescein-(TET)-ATTGATGTCTCTGCCCACGCATTGAAGT-TAMRA-3′ with their corresponding primers are appropriate .

  • Functional assays: Since CSS2A and CSS2B have distinct functional properties (CSS2A facilitates CS biosynthesis while CSS2B inhibits it), researchers can correlate antibody binding with functional outcomes to infer which variant is being detected .

  • Double-labeling techniques: Combining CSS2 antibodies with markers specific to either the ER or Golgi apparatus can help differentiate the variants based on their predominant localization patterns.

This multi-faceted approach enhances the accuracy of CSS2 variant identification in complex biological samples.

What are the key methodological considerations for optimizing CSS2 antibody performance in immunoprecipitation experiments?

Successful immunoprecipitation using CSS2 antibodies requires careful optimization of several experimental parameters:

ParameterOptimization Considerations
Lysis buffer compositionInclude appropriate detergents (e.g., NP-40, Triton X-100) at concentrations that solubilize CSS2 while preserving protein-protein interactions
Antibody concentrationTitrate to determine the minimum amount needed for efficient capture while minimizing non-specific binding
Antibody couplingConsider coupling to solid supports like Protein A/G, maleimide-Sepharose, or direct chemical coupling depending on experimental needs
Pre-clearing stepsImplement to reduce background and non-specific binding
Washing stringencyBalance between removing non-specific interactions while preserving genuine CSS2 complexes
Elution conditionsSelect appropriate methods (e.g., pH shifts, competing peptides) based on downstream applications
ControlsInclude isotype controls and samples from CSS2-knockout systems to validate specificity

Additionally, researchers should consider that CSS2 forms multimeric complexes with other enzymes like CSS1/ChSy-1, which may affect immunoprecipitation efficiency and interpretation of results .

How can computational approaches enhance the specificity and efficacy of CSS2 antibodies?

Modern computational approaches offer powerful tools for enhancing CSS2 antibody specificity and efficacy:

  • Epitope prediction and optimization: Biophysics-informed models can identify optimal epitope regions that maximize specificity for CSS2 while minimizing cross-reactivity with related proteins .

  • Binding mode identification: Computational analyses can distinguish multiple binding modes associated with specific ligands, enabling the design of antibodies with customized specificity profiles .

  • Phage display optimization: Computational models trained on phage display experimental data can predict the outcome of selection against new combinations of ligands and generate novel antibody sequences with predefined binding profiles .

  • Structural modeling: Molecular modeling of CSS2A and CSS2B provides insights into their structural differences, informing antibody design strategies that can differentiate between these variants .

  • Machine learning approaches: Neural networks can be employed to optimize antibody parameters and predict specificity based on sequence information .

Implementation of these computational strategies enables researchers to move beyond the limitations of conventional experimental approaches, producing CSS2 antibodies with enhanced specificity, sensitivity, and functional characteristics tailored to specific research applications.

What mechanisms might explain contradictory results when using CSS2 antibodies in different experimental systems?

Researchers occasionally encounter contradictory results when using CSS2 antibodies across different experimental systems. Several mechanisms can explain these discrepancies:

  • Variant-specific expression: Different cell types or tissues may express CSS2A and CSS2B in varying ratios, leading to seemingly inconsistent antibody reactivity patterns .

  • Post-translational modifications: CSS2 may undergo tissue-specific post-translational modifications that alter epitope accessibility or antibody recognition.

  • Complex formation dynamics: Since CSS2 forms heterogeneous and homogeneous complexes with other enzymes like CSS1/ChSy-1, the composition of these complexes may vary between experimental systems, affecting antibody accessibility .

  • Antibody clone variability: Different antibody clones may target distinct epitopes on CSS2, some of which might be masked in certain experimental contexts.

  • IgG subtype effects: The predominant IgG subtype of the antibody preparation can influence its functionality and behavior across different assays, similar to observations with other antibodies like Caspr2 .

Methodological approaches to resolve these contradictions include:

  • Using multiple antibody clones targeting different epitopes

  • Combining antibody detection with functional assays

  • Employing genetic approaches (siRNA, CRISPR) to validate antibody specificity

  • Characterizing antibody IgG subtypes and their functional properties in the specific experimental system

How do CSS2A and CSS2B variants differentially impact chondroitin sulfate biosynthesis at the molecular level?

The differential impact of CSS2A and CSS2B on chondroitin sulfate biosynthesis stems from their distinct molecular properties and interactions:

CSS2A positively regulates CS biosynthesis through:

  • Robust glucuronyltransferase (GlcAT) activity when expressed alone

  • Effective polymerizing activity when co-expressed with CSS1/ChSy-1

  • Formation of productive enzymatic complexes with other CS biosynthesis enzymes

In contrast, CSS2B inhibits CS biosynthesis via:

  • Reduced glucuronyltransferase activity compared to CSS2A

  • No detectable polymerizing activity when co-expressed with CSS1/ChSy-1

  • Possible competitive inhibition by forming non-productive complexes with other CS biosynthesis enzymes

Molecular modeling supports these functional differences, suggesting structural distinctions between CSS2A and CSS2B that affect their catalytic capabilities . Antibodies targeting specific regions involved in these functional differences can help elucidate the precise molecular mechanisms of CS biosynthesis regulation.

What are the implications of CSS2 antibody cross-reactivity with other glycosyltransferases in research applications?

Cross-reactivity of CSS2 antibodies with other glycosyltransferases presents both challenges and opportunities for researchers:

Potential cross-reactive targets include:

  • CSS1/ChSy-1, which shares functional domains with CSS2

  • Other enzymes involved in glycosaminoglycan synthesis

  • Proteins containing similar epitope sequences

The implications of such cross-reactivity include:

Methodological approaches to address cross-reactivity concerns:

  • Absorption controls with recombinant proteins to remove cross-reactive antibodies

  • Comprehensive validation in knockout/knockdown systems

  • Complementary detection methods like mass spectrometry to verify immunoprecipitation results

  • Biophysics-informed modeling to predict and mitigate potential cross-reactivity

Understanding and controlling for potential cross-reactivity is essential for generating reliable data in CSS2 research applications.

How can CSS2 antibodies be effectively employed to investigate the spatiotemporal dynamics of chondroitin sulfate synthesis?

Investigating the spatiotemporal dynamics of chondroitin sulfate synthesis requires sophisticated applications of CSS2 antibodies:

  • Live-cell imaging approaches:

    • Combining CSS2 antibody fragments with cell-penetrating peptides for intracellular tracking

    • Using fluorescently-labeled antibodies in permeabilized cell systems

    • Correlating CSS2 localization with markers for different Golgi compartments to track synthesis progression

  • Developmental timing analysis:

    • Employing CSS2 antibodies in developmental tissue series to track expression changes

    • Correlating CSS2 variant expression with CS production milestones

    • Using quantitative immunohistochemistry with CSS2 antibodies to measure expression levels across developmental stages

  • Advanced microscopy techniques:

    • Super-resolution microscopy with CSS2 antibodies to visualize precise subcellular localization

    • FRET-based approaches to detect CSS2 interactions with other biosynthetic enzymes

    • Combining CSS2 antibody labeling with metabolic labeling of newly synthesized CS chains

  • Pulse-chase experimental designs:

    • Using CSS2 antibodies to immunoprecipitate enzyme complexes at different time points after stimulation

    • Correlating CSS2 complex formation dynamics with CS production rates

These methodological approaches enable researchers to track both the spatial organization of CSS2 within the cellular biosynthetic machinery and the temporal sequence of events in CS synthesis, providing insights into the regulation of this complex process.

What strategies can address non-specific binding issues when using CSS2 antibodies in immunological applications?

Non-specific binding is a common challenge when working with CSS2 antibodies. Researchers can implement several methodological refinements:

  • Blocking optimization:

    • Test different blocking agents (BSA, non-fat milk, normal serum, commercial blockers)

    • Extend blocking time or increase blocker concentration

    • Use blockers from the same species as the secondary antibody

  • Antibody purification enhancements:

    • Consider additional affinity purification steps

    • Use pre-adsorption against common cross-reactive proteins

    • Implement negative selection strategies during antibody production

  • Buffer modifications:

    • Optimize salt concentration to reduce electrostatic interactions

    • Add mild detergents to reduce hydrophobic non-specific binding

    • Include carrier proteins to compete for non-specific binding sites

  • Controls and validation:

    • Always include isotype control antibodies

    • Use CSS2-depleted samples as negative controls

    • Employ peptide competition assays to confirm binding specificity

  • Signal-to-noise optimization:

    • Titrate primary and secondary antibody concentrations

    • Adjust incubation times and temperatures

    • Consider signal amplification methods for specific signals while keeping background low

These methodological refinements can significantly improve the specificity and reliability of CSS2 antibody applications across different experimental techniques.

How can researchers validate that CSS2 antibodies are detecting the intended target in complex biological samples?

Rigorous validation of CSS2 antibodies in complex biological samples requires a multi-faceted approach:

  • Genetic validation:

    • Compare antibody signal in wild-type versus CSS2 knockout/knockdown models

    • Perform rescue experiments with CSS2 variant overexpression

    • Use CRISPR-engineered epitope tags to confirm antibody specificity

  • Biochemical validation:

    • Perform peptide competition assays using the immunizing peptide

    • Pre-adsorb antibodies with recombinant CSS2 proteins

    • Use multiple antibodies targeting different CSS2 epitopes and compare results

  • Orthogonal detection methods:

    • Correlate protein detection with mRNA expression using RT-PCR or RNA-seq

    • Perform mass spectrometry analysis of immunoprecipitated material

    • Compare results with metabolic labeling of CS products

  • Functional correlation:

    • Verify that antibody-detected patterns correlate with known CSS2 functions

    • Assess whether antibody binding affects the enzymatic activity in predictable ways

    • Compare CSS2A and CSS2B detection patterns with their known differential effects on CS biosynthesis

  • Cross-platform validation:

    • Confirm findings across multiple techniques (Western blot, immunofluorescence, flow cytometry)

    • Test antibody performance in various sample preparation conditions

This comprehensive validation strategy ensures that research findings based on CSS2 antibody detection accurately reflect the biological reality of CSS2 expression and function.

How might emerging antibody engineering technologies enhance CSS2-specific research tools?

Emerging antibody engineering technologies offer exciting possibilities for developing next-generation CSS2 research tools:

  • Single-domain antibodies:

    • Development of nanobodies or single-domain antibodies against CSS2 could provide superior tissue penetration and access to cryptic epitopes

    • These smaller antibody formats may better discriminate between CSS2A and CSS2B variants in their native conformations

  • Bispecific antibody formats:

    • Engineering antibodies that simultaneously target CSS2 and its interaction partners could enable selective detection of functional complexes

    • This approach could help distinguish active from inactive CSS2 complexes in situ

  • Computationally designed antibodies:

    • Machine learning approaches trained on existing antibody-antigen interactions could generate highly specific CSS2 binding proteins

    • Biophysics-informed models can be used to design antibodies with customized specificity profiles

  • Intracellular antibodies (intrabodies):

    • Developing antibody formats that function within living cells could enable real-time tracking of CSS2 dynamics

    • These tools could help resolve questions about CSS2 trafficking and complex formation in living systems

  • Switchable affinity reagents:

    • Light-activatable or chemically-inducible antibody fragments could allow temporal control over CSS2 detection or inhibition

    • Such tools would enable precise manipulation of CSS2 function in specific cellular compartments

These advanced antibody engineering approaches could revolutionize our ability to study the complex biology of CSS2 and its role in chondroitin sulfate biosynthesis.

What role might CSS2 antibodies play in understanding disease mechanisms related to chondroitin sulfate metabolism?

CSS2 antibodies are poised to make significant contributions to understanding disease mechanisms related to chondroitin sulfate metabolism:

  • Neurodegenerative diseases:

    • CS plays important roles in neural development and neuroplasticity

    • CSS2 antibodies could help elucidate alterations in CS synthesis that contribute to conditions like Alzheimer's disease or multiple sclerosis

  • Cancer biology:

    • Changes in CS composition affect tumor cell behavior and metastasis

    • CSS2 antibodies can help map alterations in CS synthetic machinery in cancer tissues

  • Inflammatory conditions:

    • CS modulates immune cell function and inflammatory processes

    • CSS2 antibodies could reveal how changes in CS synthesis contribute to chronic inflammation

  • Rare genetic disorders:

    • Several genetic disorders affect glycosaminoglycan metabolism

    • CSS2 antibodies can help characterize the molecular consequences of mutations affecting CS biosynthesis

  • Autoimmune conditions:

    • Similar to other systems where autoantibodies target cell surface or matrix components , potential autoantibodies against CSS2 or CS could be investigated using purified CSS2 antibodies as tools

Research methodologies employing CSS2 antibodies in these contexts include:

  • Comparative tissue analysis of CSS2 expression in healthy versus diseased states

  • Investigation of post-translational modifications affecting CSS2 function in disease

  • Identification of disease-specific CSS2-containing protein complexes

  • Development of diagnostic approaches based on CSS2 expression patterns or modifications

By advancing our understanding of these disease mechanisms, CSS2 antibody research may ultimately contribute to the development of novel therapeutic approaches targeting CS biosynthesis.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.